{"id":2248,"date":"2021-06-18T10:32:34","date_gmt":"2021-06-18T14:32:34","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/hemonc-fellowship\/program-summary\/"},"modified":"2024-07-02T11:38:15","modified_gmt":"2024-07-02T15:38:15","slug":"program-summary","status":"publish","type":"page","link":"https:\/\/www.med.unc.edu\/medicine\/hemonc-fellowship\/program-summary\/","title":{"rendered":"Program Summary"},"content":{"rendered":"

\"\"<\/a><\/p>\n

Fellows usually elect to double board in hematology and medical oncology. Under certain circumstances, it may be prudent for the trainee to choose to single board in either hematology or medical oncology.<\/p>\n

The first year consists of an intensive clinical experience with both inpatient and outpatient rotations. The second and third years are more flexible and are tailored to the specific needs of the individual fellows, depending upon their chosen career tracks. A continuity clinic experience is maintained throughout the fellowship. Board preparation will begin early in the fellowship with twice weekly didactic lectures, personal access to ASCO University<\/a> and ASH Academy<\/a>, annual opportunity for all fellows to take the in-training examination in both hematology and oncology, and dedicated board review sessions.<\/p>\n

Research experiences abound, including basic or translational research experience within the Lineberger Cancer Center, the top-ranked Eshelman School of Pharmacy, or the McAllister Heart Institute, health policy and outcomes research with the 黑料网 Gillings School of Public Health<\/a> (ranked the top public school of public health in the nation by US News and World Report, 2016), as well as, clinical trials research. Numerous funding sources<\/a> are available, and our fellows have been successful at obtaining both internal and external research awards.<\/p>\n

Unique aspects of the 黑料网 Hematology-Oncology fellowship training are:<\/p>\n